Neuropace
NPCE
NPCE
24 hedge funds and large institutions have $25.9M invested in Neuropace in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
51% less capital invested
Capital invested by funds: $53.1M → $25.9M (-$27.2M)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
24
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$159K | |
| 2 | +$96.8K | |
| 3 | +$52.1K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$35.3K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$16.7K |
Top Sellers
| 1 | -$1.46M | |
| 2 | -$546K | |
| 3 | -$482K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$436K |
| 5 |
E
Ergoteles
New York
|
-$116K |